AXGN: Axogen, Inc. Common Stock Company Profile & Statistics

About

AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.

Info & Links

CEO

Michael J. Dale

Headquarters

13631 PROGRESS BLVD.,SUITE 400
ALACHUA, FL 32615, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

218

Employees

452

Axogen, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

711.27M

Enterprise Value

746.41M

Enterprise Value/EBITDA(ttm)

137.13

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

4.50

Price to Book(mrq)

8.16

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.89%

Operating Margin(ttm)

-7.91%

Profit Margin(ttm)

-5.74%

Return on Equity(ttm)

-14.91%

Return on Invested Capital(ttm)

-6.16%

Return on Assets(ttm)

-7.49%

Income Statement

Revenue(ttm)

187.34M

Revenue Per Share(ttm)

4.22

Gross Profit(ttm)

141.98M

EBITDA(ttm)³

5.44M

Net Income Available to Common(ttm)

-9.96M

Diluted EPS(ttm)

-0.32

Share Statistics

Beta (5Y Monthly)

1.00

52-Week Change

122.46%

S&P 500 52-Week Change

6.83%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

44.34M

Dividend Yield

0.00%

Float⁴

40.93M

% Held by Insiders

7.00%

% Held by Institutions

80.29%

Balance Sheet

Total Cash(mrq)

39.48M

Total Cash Per Share(mrq)

0.89

Total Debt(mrq)

68.69M

Total Debt/Equity(mrq)

66.10%

Current Ratio(mrq)

3.24%

Quick Ratio(mrq)

2.47%

Book Value Per Share(mrq)

2.35

Cash Flow

Operating Cash Flow Per Share(ytd)

0.10

Free Cash Flow(ytd)

1.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AXGN

Axogen, Inc. Common Stock

Axogen, Inc. Common Stock Profile